{ "schemaVersion": 2, "eyebrow": "Infectious Disease", "title": "Long COVID", "summary": "Long COVID is a heterogeneous postinfectious syndrome diagnosed after excluding alternative disease. Evaluation should be phenotype-directed, prioritize cardiopulmonary and neurologic danger signals, avoid indiscriminate testing, and use individualized rehabilitation that does not provoke postexertional symptom worsening.", "seoDescription": "Physician guidance on diagnosing and managing long COVID, including targeted evaluation, red flags, rehabilitation, symptom monitoring, and referral.", "clinicalQuestion": "How should clinicians evaluate and manage persistent symptoms after SARS-CoV-2 infection while excluding alternative diagnoses and preventing functional deterioration?", "specialty": "Internal Medicine", "audience": "U.S. physicians and medical trainees", "tags": [ "long COVID", "post-COVID-19 condition", "PASC", "postacute sequelae of SARS-CoV-2", "post-COVID syndrome", "postexertional symptom exacerbation" ], "keyTakeaways": [ "Use long COVID as a clinical diagnosis only when persistent symptoms after probable or confirmed SARS-CoV-2 infection are not explained by an alternative diagnosis; the WHO definition generally begins 3 months after onset and requires symptoms for at least 2 months. [1][9]", "Do not attribute chest pain, dyspnea, hypoxemia, tachycardia, focal neurologic findings, or other potentially organ-threatening presentations to long COVID before evaluating conventional acute and chronic disease mechanisms. [10][11]", "Routine broad laboratory and imaging panels are not supported; testing should be driven by the dominant symptom phenotype and examination findings. [10]", "Before prescribing exercise-based rehabilitation, screen for cardiac symptoms and assess whether exertion produces delayed symptom exacerbation; poorly matched activity progression may worsen relapse, confidence, and work participation. [4][18]", "Management is predominantly symptom-directed and multidisciplinary; current WHO guidance notes no direct intervention-study evidence for return-to-work or daily-activity rehabilitation in post-COVID-19 condition. [18]" ], "sections": [ { "id": "diagnostic-frame", "eyebrow": "Diagnosis", "heading": "Define the syndrome without missing competing disease", "intro": "Long COVID is a syndrome label, not an explanation for every postinfection symptom.", "paragraphs": [ "WHO defines post-COVID-19 condition as symptoms occurring in a person with probable or confirmed SARS-CoV-2 infection, usually 3 months from symptom onset, lasting at least 2 months, and not explained by an alternative diagnosis. NICE uses post-COVID-19 syndrome for symptoms continuing beyond 12 weeks after suspected or confirmed infection that are not otherwise explained. [1]", "Operationally, use the prior infection and temporal relationship as context, then establish the active clinical phenotype and evaluate alternative diagnoses proportionately. Long COVID can involve respiratory, cardiovascular, hematologic, neuropsychiatric, and other manifestations; many reported symptoms are subjective and examination may be unrevealing. [11]", "Do not require documented positive testing when the history supports probable infection, but do not use the syndrome label to bypass standard diagnostic pathways. Serology is not recommended to diagnose acute infection and has variable performance; it should not be used as a stand-alone confirmation of remote infection or as a test of immunity. [12]" ], "bullets": [ "Document acute illness severity, hospitalization or ICU exposure, vaccination status, prior episodes, interval recovery, relapsing pattern, functional baseline, and the symptom-exertion relationship. [9][15]", "Obtain focused examination including resting and exertional oxygenation when respiratory limitation is reported, orthostatic vital signs when dysautonomia is suspected, cardiopulmonary examination, focused neurologic examination, strength, and mental health assessment. [11]", "Record work, cognitive, mobility, and activities-of-daily-living consequences because functional impairment guides rehabilitation, accommodations, and follow-up intensity. [6][18]" ], "subsections": [], "table": { "caption": "Phenotype-directed assessment priorities in patients with persistent symptoms after COVID-19. [10][11]", "columns": [ "Presentation", "Immediate clinical priority", "Supported evaluation approach" ], "rows": [ [ "Chest pain", "Exclude emergency and serious cardiovascular disease before assigning symptoms to PASC.", "Apply the usual chest-pain history and risk-based evaluation; ECG and troponin may be considered when indicated. [10]" ], [ "Dyspnea or exertional intolerance", "Assess for cardiopulmonary disease and exertional hypoxemia.", "Consider cardiac and pulmonary testing based on symptoms and clinical findings; examine for exertional hypoxia. [10][11]" ], [ "Palpitations, presyncope, orthostatic symptoms", "Identify hemodynamic instability, arrhythmia, or orthostatic intolerance.", "Measure orthostatic vital signs and pursue cardiac evaluation when findings or symptoms warrant. [11]" ], [ "Cognitive symptoms or focal deficits", "Distinguish nonspecific cognitive complaints from acute neurologic disease or a focal syndrome.", "Perform focused neurologic examination and investigate alternative neurologic diagnoses according to the presentation. [5][11]" ], [ "Fatigue with symptom relapse after activity", "Characterize postexertional symptom exacerbation before rehabilitation planning.", "Use individualized energy management and avoid activity escalation that predictably worsens symptoms. [18]" ] ] } }, { "id": "triage-and-testing", "eyebrow": "Evaluation", "heading": "Use targeted testing and escalation", "intro": "Testing should answer a specific competing diagnosis or define a treatable organ complication.", "paragraphs": [ "Available guidance does not support routine blood testing or imaging for every patient with PASC. Instead, choose studies according to symptom pattern, severity, examination, pretest probability, and whether a result would change management. [10]", "For chest pain more than 12 weeks after infection, the recommended approach is the same as for chest pain generally: prioritize emergency and serious cardiac causes, then select tests based on the clinical syndrome. Troponin and ECG may be considered, but neither should be used indiscriminately as a screening panel. [10]", "For dyspnea, consider cardiopulmonary testing to identify pulmonary or cardiac disease. Exertional hypoxia, abnormal lung findings, elevated jugular venous pressure, tachycardia, or a pericardial rub should redirect evaluation toward specific cardiopulmonary diagnoses rather than nonspecific PASC management. [10][11]" ], "bullets": [ "Escalate urgently for new or worsening hypoxemia, clinically significant chest pain, syncope, new focal neurologic deficit, or signs suggesting myocarditis, pericarditis, thromboembolic disease, stroke, or other acute organ disease; long COVID is not a safe default diagnosis in these settings. [3][10][11]", "When an alternative diagnosis is established, treat that diagnosis and reassess which residual symptoms, if any, remain temporally linked to COVID-19. [1][10][11]", "Avoid serial testing without a clinical trigger; repeated low-yield investigations can increase patient burden and fragmentation of care. NICE evidence review notes concern about anxiety from unnecessary investigations and referrals, while also cautioning against under-referral to dedicated multidisciplinary services. [14]" ], "subsections": [], "table": { "caption": "Testing principle: link each test to a phenotype, differential diagnosis, and anticipated management action. [10][11]", "columns": [ "Clinical question", "Testing principle", "Interpretive consequence" ], "rows": [ [ "Is dyspnea due to active cardiopulmonary disease?", "Consider cardiac and pulmonary evaluation when symptoms suggest cardiopulmonary involvement. [10]", "Abnormal findings require disease-specific management or specialty referral rather than attribution to PASC alone. [10][11]" ], [ "Is chest pain potentially cardiac or emergent?", "Use standard chest-pain assessment; ECG and troponin may be considered when clinically indicated. [10]", "Prioritize exclusion of emergency and severe cardiovascular disease. [10]" ], [ "Is orthostatic intolerance present?", "Obtain orthostatic vital signs when the history suggests positional tachycardia, hypotension, presyncope, or syncope. [11]", "Objective orthostatic findings support a focused dysautonomia assessment rather than nonspecific fatigue management. [11]" ], [ "Does neurologic dysfunction require separate evaluation?", "Use symptom localization and focused examination to guide neurologic workup. [5][11]", "Focal or progressive findings should not be managed as uncomplicated long COVID. [5][11]" ] ] } }, { "id": "management", "eyebrow": "Management", "heading": "Treat identifiable disease and support function without provoking relapse", "intro": "No disease-modifying pharmacotherapy is established in the supplied evidence.", "paragraphs": [ "Management begins with treating any identified cardiopulmonary, neurologic, psychiatric, or other diagnosis using its established pathway. For residual long-COVID symptoms, available sources support symptom-directed, individualized, interdisciplinary care rather than a uniform medication regimen. [10][11][15]", "Rehabilitation should follow exclusion of life-threatening complications and relevant alternative diagnoses. Referral options may include physical and occupational therapy, pulmonary or cardiac rehabilitation, and speech or swallowing therapy, selected for the patient’s impairment pattern. Cardiac symptoms should be screened for before initiating an exercise program, with further cardiac evaluation when indicated. [4]", "For patients whose symptoms worsen after physical or cognitive activity, do not assume deconditioning alone. WHO notes that activity-associated exacerbation or relapse can contribute to loss of confidence and work loss, and recommends that patients establish energy self-management at home before return to work. The guideline also states that direct intervention evidence for return-to-activity and work rehabilitation is lacking. [18]" ], "bullets": [ "Set functional goals rather than requiring complete symptom resolution before measuring benefit: safe activities of daily living, cognitive endurance, mobility, sleep, and graded return to valued roles when tolerated. [6][18]", "Use a coordinated plan when multiple systems are involved; multidisciplinary ambulatory post-COVID programs have incorporated pulmonary, rehabilitation, home monitoring, pharmacy, speech-language, physical, and occupational therapy services. [15]", "Arrange follow-up based on trajectory and risk: sooner for progressive symptoms, new objective abnormalities, exertional hypoxemia, unstable hemodynamics, or inability to maintain basic function. [10][11][15]", "Do not present pharmacologic, supplement, anticoagulant, antiviral, or immunomodulatory treatment as established long-COVID therapy on the basis of the supplied sources; no dosing recommendation is supported here. [10][18]" ], "subsections": [ { "heading": "Return to exercise, work, and daily activity", "paragraphs": [ "A rehabilitation prescription should specify baseline activity tolerance, symptom response during and after activity, pacing or energy-management strategy, and criteria for holding or reducing activity. This is particularly important when physical or mental activity worsens symptoms. [16][18]", "Work planning should be individualized and may require staged duties, reduced cognitive or physical load, remote work, or intermittent leave. Evidence for a specific rehabilitation protocol remains indirect; communicate this uncertainty rather than prescribing a fixed progression. [18]" ], "bullets": [ "Before an exercise program, screen for cardiac symptoms and pursue cardiac assessment when symptoms indicate. [4]", "If activity causes delayed worsening or relapse, prioritize symptom-contingent pacing and reassess the rehabilitation plan rather than automatically increasing training load. [18]" ] } ], "table": { "caption": "Practical care model for long COVID, based on phenotype-directed assessment and multidisciplinary rehabilitation principles. [4][10][15][18]", "columns": [ "Care component", "Action", "Trigger to modify plan" ], "rows": [ [ "Diagnostic safety", "Evaluate new or concerning symptoms using standard organ-specific pathways before labeling them PASC. [10][11]", "New chest pain, hypoxemia, syncope, focal neurologic signs, or progressive cardiopulmonary symptoms. [10][11]" ], [ "Rehabilitation", "Refer for targeted PT, OT, pulmonary/cardiac rehabilitation, or speech/swallow therapy after clinically important alternatives are addressed. [4]", "Cardiac symptoms, exertional relapse, or inability to tolerate the current plan. [4][18]" ], [ "Energy management", "Assess activity-related symptom worsening and build a sustainable home routine before work resumption. [18]", "Relapse or symptom exacerbation after physical or cognitive activity. [18]" ], [ "Care coordination", "Use multidisciplinary or integrated services when multisystem impairment or functional disability exceeds primary-care capacity. [14][15]", "Fragmented evaluations, persistent disability, or need for multiple rehabilitation disciplines. [14][15]" ] ] } }, { "id": "prognosis-and-communication", "eyebrow": "Prognosis", "heading": "Communicate uncertainty while validating functional impact", "intro": "Course is variable, and symptom burden may persist for months or years.", "paragraphs": [ "Long COVID has a heterogeneous, relapsing-remitting course. Estimates in a recent review suggest persistent symptoms in approximately 6.6% to 10.4% of infected individuals, although estimates vary substantially with definition, population, variant era, and ascertainment method. [6][9]", "The clinical burden is not limited to symptom counts: fatigue, palpitations, cognitive dysfunction, and dyspnea can affect work performance, social participation, and self-perception. Functional assessment should therefore be a routine outcome measure rather than an optional add-on. [6]", "Explain that uncertainty about mechanism and treatment does not imply that symptoms are trivial. At the same time, communicate that new symptoms and changes in pattern require reassessment for non-PASC diagnoses, particularly cardiopulmonary and neurologic disease. [10][11]" ], "bullets": [ "Use shared decision-making when choosing testing, referrals, and rehabilitation intensity; patient burden from fragmented care and unnecessary testing must be balanced against the risk of under-recognizing organ disease. [14]", "Document objective findings and functional limitations longitudinally to distinguish stable chronic symptoms from new disease or progressive impairment. [11][15]" ], "subsections": [], "table": { "caption": "Counseling points grounded in the variable clinical course and limited direct rehabilitation evidence. [6][18]", "columns": [ "Message", "Clinical implication" ], "rows": [ [ "Symptoms may persist and fluctuate over months or longer. [6]", "Plan scheduled reassessment around function, symptom pattern, and emerging red flags rather than promising a fixed recovery timeline." ], [ "Exertion can worsen symptoms in some patients. [16][18]", "Tailor activity progression to post-activity response and reduce exposure to predictable relapse." ], [ "Evidence for return-to-work rehabilitation protocols is limited. [18]", "Use individualized accommodations and revise them according to observed tolerance and functional recovery." ] ] } } ], "faq": [ { "question": "Is long COVID a diagnosis of exclusion?", "answer": "Yes. WHO and NICE definitions require that symptoms not be explained by an alternative diagnosis. Evaluate symptom-specific differentials and acute organ-threatening conditions before attributing complaints to PASC. [1][10][11]" }, { "question": "Should every patient with long COVID receive broad laboratory testing and imaging?", "answer": "No. Available clinical guidance states that routine blood tests and imaging are not supported for all patients with PASC. Select tests according to the symptom phenotype, examination, and whether results will change management. [10]" }, { "question": "How should dyspnea after COVID-19 be evaluated?", "answer": "Assess for exertional hypoxemia and other cardiopulmonary findings, then consider cardiac and pulmonary testing when the presentation suggests cardiopulmonary disease. Do not assume dyspnea is uncomplicated PASC without evaluating plausible alternatives. [10][11]" }, { "question": "Can patients with long COVID start a standard graded exercise program?", "answer": "Not automatically. Screen for cardiac symptoms before exercise, and determine whether physical or cognitive exertion causes symptom exacerbation or relapse. When it does, use individualized energy management and adjust rehabilitation rather than applying a fixed progression. [4][18]" }, { "question": "Are there established drug treatments for long COVID?", "answer": "The supplied evidence does not establish a disease-modifying pharmacotherapy or support medication dosing recommendations for long COVID. Treat identified alternative diagnoses and use symptom-directed, multidisciplinary care. [10][15][18]" } ], "references": [ { "number": 1, "title": "Long COVID - Symptoms, diagnosis and treatment | BMJ Best Practice US", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/3000327", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com" }, { "number": 2, "title": "Short-term and Long-term Rates of Postacute Sequelae ...", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784918", "authors": "jamanetwork.com", "host": "jamanetwork.com" }, { "number": 3, "title": "Extrapulmonary manifestations of COVID-19 | Nature Medicine", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41591-020-0968-3", "authors": "www.nature.com", "host": "www.nature.com" }, { "number": 4, "title": "An overview of clinical presentation and... : The Nurse Practitioner", "detail": "journals.lww.com", "url": "https://journals.lww.com/tnpj/fulltext/2025/11000/an_overview_of_clinical_presentation_and.9.aspx", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 5, "title": "Neurologic Complications of COVID-19", "detail": "journals.lww.com", "url": "https://journals.lww.com/continuum/fulltext/2023/06000/neurologic_complications_of_covid_19.14.aspx", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 6, "title": "Long COVID: current research and future directions : Infectious Diseases & Immunity", "detail": "journals.lww.com", "url": "https://journals.lww.com/idi/_layouts/15/oaks.journals/downloadpdf.aspx?an=02211172-202510000-00006", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 7, "title": "Long COVID : Journal of Nature and Science of Medicine", "detail": "journals.lww.com", "url": "https://journals.lww.com/jnsm/fulltext/2023/06010/long_covid__the_long_term_consequences_of_covid_19.2.aspx", "authors": "journals.lww.com", "host": "journals.lww.com" }, { "number": 8, "title": "Post-COVID Conditions: Information for Healthcare Providers", "detail": "archive.cdc.gov", "url": "https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html", "authors": "archive.cdc.gov", "host": "archive.cdc.gov" }, { "number": 9, "title": "Postacute Sequelae of SARS-CoV-2 in University Setting - Volume 29, Number 3—March 2023 - Emerging Infectious Diseases journal - CDC", "detail": "wwwnc.cdc.gov", "url": "https://wwwnc.cdc.gov/eid/article/29/3/22-1522_article", "authors": "wwwnc.cdc.gov", "host": "wwwnc.cdc.gov" }, { "number": 10, "title": "Clinical Practice Guideline Recommendations for Post-Acute Sequelae of COVID-19", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12802050", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov" }, { "number": 11, "title": "Postacute Coronavirus (COVID-19) Syndrome - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK570608", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 12, "title": "Features, Evaluation, and Treatment of Coronavirus (COVID-19) - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK554776", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 13, "title": "Post–COVID-19 Condition Treatment and Management Rapid ...", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK601822", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov" }, { "number": 14, "title": "COVID-19 rapid guideline", "detail": "www.nice.org.uk", "url": "https://www.nice.org.uk/guidance/ng188/evidence/evidence-review-i-signs-and-symptoms-update-pdf-13307838597", "authors": "www.nice.org.uk", "host": "www.nice.org.uk" }, { "number": 15, "title": "Post-COVID-19 Recovery Care: The Need for the Interprofessional Approach | COVID in Focus - American College of Chest Physicians", "detail": "www.chestnet.org", "url": "https://www.chestnet.org/guidelines-and-topic-collections/topic-collections/covid-19/covid-in-focus/post-covid-19-recovery-care-the-need-for-the-interprofessional-approach", "authors": "www.chestnet.org", "host": "www.chestnet.org" }, { "number": 16, "title": "Postacute Sequelae of SARS-CoV-2 in University Setting", "detail": "wwwnc.cdc.gov", "url": "https://wwwnc.cdc.gov/eid/article/29/3/pdfs/22-1522.pdf", "authors": "wwwnc.cdc.gov", "host": "wwwnc.cdc.gov" }, { "number": 17, "title": "nxi.11.issue-3.pdf", "detail": "www.neurology.org", "url": "https://www.neurology.org/cms/asset/dc77ea11-aeb6-4c13-8787-62264b7051da/nxi.11.issue-3.pdf", "authors": "www.neurology.org", "host": "www.neurology.org" }, { "number": 18, "title": "Clinical management of COVID-19: living guideline, June 2025", "detail": "iris.who.int", "url": "https://iris.who.int/server/api/core/bitstreams/d1021eff-f570-4c22-b630-a44bf4267a6c/content", "authors": "iris.who.int", "host": "iris.who.int" } ], "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.", "citations": [ { "number": 1, "title": "Long COVID - Symptoms, diagnosis and treatment | BMJ Best Practice US", "detail": "bestpractice.bmj.com", "url": "https://bestpractice.bmj.com/topics/en-us/3000327", "authors": "bestpractice.bmj.com", "host": "bestpractice.bmj.com", "snippet": "The World Health Organization defines post-COVID-19 condition (long COVID) as a condition that occurs in adults with a history of probable or confirmed SARS-CoV-2 infection, usually occurring 3 months from the onset of COVID-19 symptoms and lasting for at least 2 months, that cannot be explained by ", "score": 0.3673843 }, { "number": 2, "title": "Short-term and Long-term Rates of Postacute Sequelae ...", "detail": "jamanetwork.com", "url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784918", "authors": "jamanetwork.com", "host": "jamanetwork.com", "snippet": "by D Groff · 2021 · Cited by 1283 — This systematic review estimates organ system–specific frequency and evolution of postacute sequelae of COVID-19 infection.", "score": 0.18400416 }, { "number": 3, "title": "Extrapulmonary manifestations of COVID-19 | Nature Medicine", "detail": "www.nature.com", "url": "https://www.nature.com/articles/s41591-020-0968-3", "authors": "www.nature.com", "host": "www.nature.com", "snippet": "COVID-19-specific considerations\n\n Continue adherence to established guidelines for acute ischemic stroke, including thrombolysis and thrombectomy209 pandemic: On Behalf of the American Heart Association/American Stroke Association Stroke Council Leadership. Stroke 51, 1910–1912 (2020).\")\n Adapt pos", "score": 0.22410676 }, { "number": 4, "title": "An overview of clinical presentation and... : The Nurse Practitioner", "detail": "journals.lww.com", "url": "https://journals.lww.com/tnpj/fulltext/2025/11000/an_overview_of_clinical_presentation_and.9.aspx", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "## REHABILITATION\n\nReferring individuals with long COVID to multidisciplinary assessment and rehabilitation services, including physical and occupational therapy, pulmonary or cardiac rehabilitation, and speech and swallowing therapy, is recommended once life-threatening complications and alternativ", "score": 0.5013922 }, { "number": 5, "title": "Neurologic Complications of COVID-19", "detail": "journals.lww.com", "url": "https://journals.lww.com/continuum/fulltext/2023/06000/neurologic_complications_of_covid_19.14.aspx", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "### ESSENTIAL POINTS\n\nNeurologists must be aware of the potential acute, postacute, and vaccine-associated neurologic complications associated with COVID-19 and be poised to serve as integral members of multidisciplinary care teams for patients with COVID-19–related conditions.\n\nRelated Continuum Au", "score": 0.41948205 }, { "number": 6, "title": "Long COVID: current research and future directions : Infectious Diseases & Immunity", "detail": "journals.lww.com", "url": "https://journals.lww.com/idi/_layouts/15/oaks.journals/downloadpdf.aspx?an=02211172-202510000-00006", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "Long coronavirus disease (COVID), also known as post-COVID-19 condition or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), is a persistent and complex condition that follows acute COVID-19 illness. It is characterized by a wide range of symptoms ", "score": 0.34886748 }, { "number": 7, "title": "Long COVID : Journal of Nature and Science of Medicine", "detail": "journals.lww.com", "url": "https://journals.lww.com/jnsm/fulltext/2023/06010/long_covid__the_long_term_consequences_of_covid_19.2.aspx", "authors": "journals.lww.com", "host": "journals.lww.com", "snippet": "Acute COVID-19 symptoms may last from a few days to weeks, possibly due to the virus and body's initial immune response to infection. However, in around 10%–35% of patients who suffered acute COVID-19, symptoms persist after recovery for weeks to months following a relapsing and remitting course, wh", "score": 0.3446204 }, { "number": 8, "title": "Post-COVID Conditions: Information for Healthcare Providers", "detail": "archive.cdc.gov", "url": "https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html", "authors": "archive.cdc.gov", "host": "archive.cdc.gov", "snippet": "32. Greenhalgh T, Knight M, A’Court C, et al. Management of Post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi:10.1136/bmj.m3026\n33. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. Accessed at: \n34. Sisó-Almirall A, Brito-Zerón P, Conangla Ferrín L, et al. Long Covid", "score": 0.43438992 }, { "number": 9, "title": "Postacute Sequelae of SARS-CoV-2 in University Setting - Volume 29, Number 3—March 2023 - Emerging Infectious Diseases journal - CDC", "detail": "wwwnc.cdc.gov", "url": "https://wwwnc.cdc.gov/eid/article/29/3/22-1522_article", "authors": "wwwnc.cdc.gov", "host": "wwwnc.cdc.gov", "snippet": "It is estimated that 1 in 3 Americans who have SARS-CoV-2 infection will experience symptoms related to postacute sequelae of SARS-CoV-2 (1), also referred to as long COVID (other terms include long-haul coronavirus disease, post–-COVID-19 conditions, or chronic COVID-19) (2). The length of time tha", "score": 0.27327052 }, { "number": 10, "title": "Clinical Practice Guideline Recommendations for Post-Acute Sequelae of COVID-19", "detail": "pmc.ncbi.nlm.nih.gov", "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12802050", "authors": "pmc.ncbi.nlm.nih.gov", "host": "pmc.ncbi.nlm.nih.gov", "snippet": "Persistent chest pain has been reported in approximately 10–20% of patients 30–60 days after acute SARS-CoV-2 infection . For patients presenting with chest pain more than 12 weeks after acute SARS-CoV-2 infection, an appropriate approach is obtaining the same medical history and evaluation as for p", "score": 0.5142789 }, { "number": 11, "title": "Postacute Coronavirus (COVID-19) Syndrome - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK570608", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Hematologic\n\nNeuropsychiatric\n\n## Differential Diagnosis\n\nKnowledge of long COVID is limited at this time, and any organ system can potentially be affected. Hence, long COVID should be considered a diagnosis of exclusion. All other well-described complications associated with COVID-19 and other acut", "score": 0.50446826 }, { "number": 12, "title": "Features, Evaluation, and Treatment of Coronavirus (COVID-19) - StatPearls - NCBI Bookshelf", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK554776", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "Other Laboratory Assessment\n\nImaging ModalitiesThiss viral illness commonly manifests as pneumonia, so radiological imaging such as chest x-rays, lung ultrasounds, and chest computed tomography (CT) are often obtained. However, there are no guidelines regarding the timing and choice of pulmonary ima", "score": 0.37291673 }, { "number": 13, "title": "Post–COVID-19 Condition Treatment and Management Rapid ...", "detail": "www.ncbi.nlm.nih.gov", "url": "https://www.ncbi.nlm.nih.gov/books/NBK601822", "authors": "www.ncbi.nlm.nih.gov", "host": "www.ncbi.nlm.nih.gov", "snippet": "83. exp Severe acute respiratory syndrome coronavirus 2/\n\n84. (COVID\\ or coronavirus\\ or corona virus\\ or 2019nCoV or 19nCoV or COVID19\\ or COVID or SARS-COV-2 or SARSCOV-2 or SARS-COV2 or SARSCOV2 or SARS coronavirus 2 or Severe Acute Respiratory Syndrome Coronavirus 2 or Severe Acute Respiratory S", "score": 0.26086035 }, { "number": 14, "title": "COVID-19 rapid guideline", "detail": "www.nice.org.uk", "url": "https://www.nice.org.uk/guidance/ng188/evidence/evidence-review-i-signs-and-symptoms-update-pdf-13307838597", "authors": "www.nice.org.uk", "host": "www.nice.org.uk", "snippet": "Post-acute COVID-19 Syndrome. Incidence and risk - Sample size less than 10,000 COVID-19 rapid evidence review: Signs, symptoms and prevalence (November 2021) 75 of 78 © NICE 2021. All rights reserved. Subject to Notice of rights. factors: a Mediterranean cohort study. The Journal of infection Nehme", "score": 0.2556901 }, { "number": 15, "title": "Post-COVID-19 Recovery Care: The Need for the Interprofessional Approach | COVID in Focus - American College of Chest Physicians", "detail": "www.chestnet.org", "url": "https://www.chestnet.org/guidelines-and-topic-collections/topic-collections/covid-19/covid-in-focus/post-covid-19-recovery-care-the-need-for-the-interprofessional-approach", "authors": "www.chestnet.org", "host": "www.chestnet.org", "snippet": "A multidisciplinary, interprofessional approach to address the long-term pulmonary and nonpulmonary sequelae of patients who survive COVID-19 is being implemented in many post-COVID-19 ambulatory programs. Given that the long-term outcomes for survivors of COVID-19 remain to be determined, outcome p", "score": 0.55072874 }, { "number": 16, "title": "Postacute Sequelae of SARS-CoV-2 in University Setting", "detail": "wwwnc.cdc.gov", "url": "https://wwwnc.cdc.gov/eid/article/29/3/pdfs/22-1522.pdf", "authors": "wwwnc.cdc.gov", "host": "wwwnc.cdc.gov", "snippet": "Rivera SC, McMullan C, Chandan JS, et al.; TLC Study Group. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114:428–42. 01410768211032850 12. Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-C", "score": 0.31700373 }, { "number": 17, "title": "nxi.11.issue-3.pdf", "detail": "www.neurology.org", "url": "https://www.neurology.org/cms/asset/dc77ea11-aeb6-4c13-8787-62264b7051da/nxi.11.issue-3.pdf", "authors": "www.neurology.org", "host": "www.neurology.org", "snippet": "fl ammation). Similarly, the predictive value of in fl ammatory biomarkers in regards to cognitive PASC symptoms and global health outcomes remains unknown. Using data prospectively collected from the CONTAIN COVID-19 randomized clinical trial (CONTAIN-RCT), which investigated the e ff ects of conva", "score": 0.392221 }, { "number": 18, "title": "Clinical management of COVID-19: living guideline, June 2025", "detail": "iris.who.int", "url": "https://iris.who.int/server/api/core/bitstreams/d1021eff-f570-4c22-b630-a44bf4267a6c/content", "authors": "iris.who.int", "host": "iris.who.int", "snippet": "F, Hossain P, Islam AMK, et al. Living with \"long COVID\": A systematic review and meta-synthesis of qualitative evidence. PloS one 2023;18(2):e0281884 Pubmed Journal 569. Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk Factors Associated With Post-COVID-19 Condit", "score": 0.37079534 } ], "publishedAt": "2026-08-21T01:38:20.245728+00:00", "updatedAt": "2026-08-21T01:38:20.245728+00:00", "readingMinutes": 5, "slug": "long-covid" }